Get App Open
In App
Credit Cards
Open App
Loans
Loans

Gainers & Losers: Stocks that moved the most on December 2

Moneycontrol News | December 02, 2024 / 15:40 IST
1/11
Nifty and Sensex rallied for the second straight session on December 2, driven by sharp gains in pharma, realty, and auto stocks. The broader market also showed resilience, and surged to its highest in a month, lifting sentiment despite lingering volatility and valuation concerns. At close, the Sensex was up 0.6 percent or 458 points at 80,260 and Nifty 50 was up 143 points at 24,274.
Nifty and Sensex rallied for the second straight session on December 2, driven by sharp gains in pharma, realty, and auto stocks. The broader market also showed resilience, and surged to its highest in a month, lifting sentiment despite lingering volatility and valuation concerns. At close, the Sensex was up 0.6 percent or 458 points at 80,260 and the Nifty 50 was up 143 points at 24,274.
2/11
Dixon Technologies (India) | CMP: Rs X | Shares rose nearly x pecent after its wholly-owned subsidiary, Padget Electronics, announced plans to commence mass production of Google Pixel smartphones in collaboration with Compal Smart Device India for Compal's client, Google Information Services India. The production is part of a contract manufacturing agreement signed in February with Compal Smart Device India and will take place at Padget's Noida plant.
Dixon Technologies (India) | CMP: Rs 16,770 | Shares rose over 6 percent after its wholly-owned subsidiary, Padget Electronics, announced plans to commence mass production of Google Pixel smartphones in collaboration with Compal Smart Device India for Compal's client, Google Information Services India. The production is part of a contract manufacturing agreement signed in February with Compal Smart Device India and will take place at Padget's Noida plant.
3/11
Biocon | CMP: Rs X | Shares rose X percent after the U.S. FDA approved Biocon Biologics' Yesintek, a biosimilar to J&J's Stelara. Yesintek, a monoclonal antibody, is approved for the treatment of Crohn's disease, olcerative colitis, plaque psoriasis, and psoriatic arthritis.
Biocon | CMP: Rs 375 | Shares rose nearly 3 percent after the U.S. FDA approved Biocon Biologics' Yesintek, a biosimilar to J&J's Stelara. Yesintek, a monoclonal antibody, is approved for the treatment of Crohn's disease, ulcerative colitis, plaque psoriasis, and psoriatic arthritis.
4/11
Emami Realty | CMP: Rs X | Shares were locked in a 5 percent upper circuit at Rs 111.7 following the launch of its premium residential project, Emami Aamod, in New Alipore. The project is expected to generate revenue of approximately Rs 850 crore.
Emami Realty | CMP: Rs 112 | Shares were locked in a 5 percent upper circuit at Rs 111.7 following the launch of its premium residential project, Emami Aamod, in New Alipore. The project is expected to generate revenue of approximately Rs 850 crore.
5/11
Atul Auto | CMP: Rs X | Shares were locked in a 5 percent upper circuit after the company reported robust November sales figures. Domestic sales volumes for Atul Auto stood at 2,535 units in November 2024, marking a 19.4 percent increase compared to 2,123 units in November 2023.
Atul Auto | CMP: Rs 595 | Shares were locked in a 5 percent upper circuit after the company reported robust November sales figures. Domestic sales volumes for Atul Auto stood at 2,535 units in November 2024, marking a 19.4 percent increase compared to 2,123 units in November 2023.
6/11
Cement stocks | Shares of cement companies rallied led by Ultratech Cement, which surged over 3 percent to top the Nifty 50 gainers list after Jefferies expressed optimism about a recovery for Indian cement companies in the second half of the fiscal year. Other players, including Shree Cement, India Cements, JK Lakshmi Cement, JK Cement, Andhra Cements, and ACC, also advanced by 2-3 percent.
Cement stocks | Shares of cement companies rallied led by Ultratech Cement, which surged nearly 4 percent to top the Nifty 50 gainers list after Jefferies expressed optimism about a recovery for Indian cement companies in the second half of the fiscal year. Other players, including Shree Cement, India Cements, JK Lakshmi Cement, JK Cement, Andhra Cements, and ACC, also advanced by 0.5-5 percent.
7/11
C. E. Info Systems | CMP: Rs X | Shares tumbled X percent after the company decided to segregate its B2C (consumer-tech) aspirations from its core (B2B/B2B2C) business.
C. E. Info Systems | CMP: Rs 1,690 | Shares tumbled 3.6 percent after the company decided to segregate its B2C (consumer-tech) aspirations from its core (B2B/B2B2C) business.
8/11
Cipla | CMP: Rs X | Shares fell nearly 2 percent after as many as 1.4 crore shares or 1.7 percent equity of the company changed hands in four block deals. CNBC-TV18 had reported earlier that Cipla's promoters were considering selling up to 1.4 crore shares. The offer price was set at Rs 1,442 per share. The total transaction size was estimated at around Rs 2,000 crore, according to CNBC-TV18's sources.
Cipla | CMP: Rs 1,513 | Shares fell nearly 1.4 percent after as many as 1.4 crore shares or 1.7 percent equity of the company changed hands in four block deals. CNBC-TV18 had reported earlier that Cipla's promoters were considering selling up to 1.4 crore shares. The offer price was set at Rs 1,442 per share. The total transaction size was estimated at around Rs 2,000 crore, according to CNBC-TV18's sources.
9/11
SML Isuzu | CMP: Rs X | Shares declined by X percent after the company reported a 16.7 percent drop in total sales for November, with 539 units sold compared to 647 units in the same period last year.
SML Isuzu | CMP: Rs 1,609 | Shares declined by nearly 3 percent after the company reported a 16.7 percent drop in total sales for November, with 539 units sold compared to 647 units in the same period last year.
10/11
Hyundai Motor India | CMP: Rs X | Shares slipped X percent after the company reported a sharp decline in November sales. The drop comes despite it achieving the highest ever monthly rural contribution. During the month, the Creta-maker registered total monthly sales of 61,250 units, lower by 7 percent from the same month last year when the company sold over 65,000 units.
Hyundai Motor India | CMP: Rs 2,16,000 | Shares slipped over 1 percent after the company reported a sharp decline in November sales. The drop comes despite it achieving the highest ever monthly rural contribution. During the month, the Creta-maker registered total monthly sales of 61,250 units, lower by 7 percent from the same month last year when the company sold over 65,000 units.
11/11
Cochin Shipyard | CMP: Rs X | Shares hit a 5 percent upper circuit after the company signed a ₹1,000 crore contract with the Ministry of Defence (MoD), Government of India.
Cochin Shipyard | CMP: Rs 1,656 | Shares hit a 5 percent upper circuit after the company signed a Rs 1,000 crore contract with the Ministry of Defence (MoD), Government of India.

Discover the latest Business News, Budget 2025 News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347